NCT06899438

Does Botulinum Toxin Type-A Injection an Effective Way of Relieving Pain in Myofascial Pain Syndrome Patients or Not

Completed NA Last updated 9 January 2026

What this trial tests

NA trial testing Botulinum Toxin A Injection in Myofacial Pain Syndromes in 38 participants. Completed in 26 January 2010.

Timeline

26 August 2009

Primary endpoint
26 January 2010

26 January 2010

Quick facts

Lead sponsor	Bursa City Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	38
Start date	26 August 2009
Primary completion	26 January 2010
Estimated completion	26 January 2010

Drugs / interventions tested

• Botulinum Toxin A Injection
• Prilocaine HCl % 2 injectable solution — full drug profile →

Conditions studied

• Myofacial Pain Syndromes — all drugs for Myofacial Pain Syndromes →

Sponsor

Bursa City Hospital

Who can join

Adults 20 to 60, any sex, with Myofacial Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this research prilocaine and botulinum toxin (BoNT-A) interventions prospectively compared to find out the effect of BoNT-A injection on myofascial pain syndrome (MPS).

The main question it aims to answer is: Does Botulinum Toxin Type-A an Effective Way of Relieving Pain in Myofascial Pain Syndrome or not?

For this purpose thirty-eight patients randomly assigned into two study groups. While BoNT-A injection group (BIG group n=19) treated with 20 units of toxin to each trigger point (TP), remaining treated with 2 ml prilocaine (PIG group n=19) with same procedure.

Pre-treatment, 2nd and 6th weeks findings were clinically recorded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.